
Lantheus Holdings Inc
LNTHHealthcare|Drug Manufacturers - Specialty & Generic|USA
$105.64
-0.34 (-0.32%)
DCF (FCF)
$69.11
Tangible Book
$4.10
Graham Number
$22.41
Earnings Power
$25.99
Analyst Estimates
annual
{
"date": [
"202612",
"202712",
"202812",
"202912",
"203012"
],
"revenue_estimate": [
1463.48,
1652.43,
1867.74,
2053.44,
2202.47
],
"ebit_estimate": [
477.13,
540.83,
652.63,
730.63,
780.83
],
"ebitda_estimate": [
516.93,
600.97,
703.6,
786.94,
null
],
"net_income_estimate": [
356.57,
433.69,
500.54,
523.93,
533.7
],
"per_share_eps_estimate": [
4.47,
5.49,
7.27,
6.32,
null
],
"eps_nri_estimate": [
5.3,
6.37,
7.59,
8.01,
8.6
],
"dividend_estimate": [
null,
null,
null,
null,
null
],
"book_value_per_share_estimate": [
null,
null,
null,
null,
null
],
"pretax_income_estimate": [
469.33,
545.58,
667.39,
760.06,
918
],
"operating_cash_flow_per_share_estimate": [
null,
null,
null,
null,
null
],
"roa_estimate": [
null,
null,
null,
null,
null
],
"roe_estimate": [
20.49,
20.47,
20.17,
19.09,
null
],
"gross_margin_estimate": [
64.75,
65.89,
66.88,
65.8,
68
],
"operating_cash_flow_estimate": [
null,
null,
null,
null,
null
],
"pettm_estimate": [
23.64,
19.24,
14.54,
16.7,
null
],
"long_term_growth_rate_mean": 8.86,
"long_term_revenue_growth_rate_mean": "7.22",
"future_per_share_eps_estimate_growth": 28.08,
"future_eps_nri_estimate_growth": 8.86,
"future_revenue_estimate_growth": 7.22,
"future_ebit_estimate_growth": null,
"future_ebitda_estimate_growth": 19.93,
"future_dividend_estimate_growth": null,
"future_net_income_estimate_growth": 7.76,
"future_pretax_income_estimate_growth": 27.31,
"future_book_value_per_share_estimate_growth": null,
"future_roa_estimate_growth": null,
"future_roe_estimate_growth": -15.53,
"future_gross_margin_estimate_growth": 2.93,
"future_operating_cash_flow_per_share_estimate_growth": null
}
quarterly
{
"date": [
"202606",
"202609",
"202612",
"202703",
"202706",
"202709",
"202712",
"202803"
],
"revenue_estimate": [
362.04,
360.81,
371.19,
387.03,
395.74,
408.76,
428.25,
437.41
],
"ebit_estimate": [
117.33,
117.6,
123.6,
113.81,
125.4,
139,
157.9,
null
],
"ebitda_estimate": [
122.88,
124.23,
116.9,
158.48,
null,
null,
null,
null
],
"net_income_estimate": [
85.35,
85.4,
91.36,
104.09,
114.25,
122.36,
135.22,
null
],
"per_share_eps_estimate": [
0.99,
1.01,
1.14,
1.44,
1.56,
1.62,
1.7,
null
],
"eps_nri_estimate": [
1.3,
1.29,
1.36,
1.41,
1.49,
1.55,
1.88,
1.55
],
"dividend_estimate": [
null,
null,
null,
null,
null,
null,
null,
null
],
"book_value_per_share_estimate": [
null,
null,
null,
null,
null,
null,
null,
null
],
"pretax_income_estimate": [
114.17,
114.33,
122.21,
115.8,
125.9,
139.5,
158.3,
null
],
"operating_cash_flow_per_share_estimate": [
null,
null,
null,
null,
null,
null,
null,
null
],
"roa_estimate": [
null,
null,
null,
null,
null,
null,
null,
null
],
"roe_estimate": [
null,
null,
null,
null,
null,
null,
null,
null
],
"gross_margin_estimate": [
65.05,
64.75,
64.86,
66,
66,
66,
66,
null
],
"operating_cash_flow_estimate": [
null,
null,
null,
null,
null,
null,
null,
null
],
"pettm_estimate": [
23.14,
20.55,
18.36,
16.72,
null,
null,
null,
null
],
"long_term_growth_rate_mean": 8.86,
"long_term_revenue_growth_rate_mean": "7.22",
"future_per_share_eps_estimate_growth": 28.08,
"future_eps_nri_estimate_growth": 8.86,
"future_revenue_estimate_growth": 7.22,
"future_ebit_estimate_growth": null,
"future_ebitda_estimate_growth": 19.93,
"future_dividend_estimate_growth": null,
"future_net_income_estimate_growth": 7.76,
"future_pretax_income_estimate_growth": 27.31,
"future_book_value_per_share_estimate_growth": null,
"future_roa_estimate_growth": null,
"future_roe_estimate_growth": -15.53,
"future_gross_margin_estimate_growth": 2.93,
"future_operating_cash_flow_per_share_estimate_growth": null
}